1. Home
  2. BRID vs CLNN Comparison

BRID vs CLNN Comparison

Compare BRID & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgford Foods Corporation

BRID

Bridgford Foods Corporation

HOLD

Current Price

$5.43

Market Cap

53.6M

ML Signal

HOLD

Logo Clene Inc.

CLNN

Clene Inc.

BUY

Current Price

$3.99

Market Cap

57.4M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
BRID
CLNN
Founded
1932
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.6M
57.4M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
BRID
CLNN
Price
$5.43
$3.99
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $32.20
AVG Volume (30 Days)
3.5K
★ 82.5K
Earning Date
08-24-2026
11-12-2026
Dividend Yield
★ 1.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $174,257,000.00
$200,000.00
Revenue This Year
N/A
$24.70
Revenue Next Year
N/A
$9,228.71
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 4.21
N/A
52 Week Low
$5.27
$3.02
52 Week High
$8.50
$13.50

Technical Indicators

Market Signals
Indicator
BRID
CLNN
Relative Strength Index (RSI) 42.74 53.33
Support Level $5.35 $3.92
Resistance Level $5.96 $4.05
Average True Range (ATR) 0.26 0.28
MACD 0.00 0.07
Stochastic Oscillator 24.18 90.34

Price Performance

Historical Comparison
BRID
CLNN

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The two business segments are: the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches, among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, mass merchandise, and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: